Fibroblast Growth Factor 23 and Hypophosphatemia: A Case of Hypophosphatemia along the Rickets-Osteomalacia Spectrum

Publisher： Karger

E-ISSN： 1664-5502|7|1|60-65

ISSN： 1664-3828

Source： Cardiorenal Medicine, Vol.7, Iss.1, 2016-09, pp. : 60-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Marked Hypophosphatemia in a Patient with Acute Leukemia

By  

Nephron, Vol. 83, Iss. 2, 1999-09 ,pp. : 173-173

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 and Vascular Calcification: Is It Set in Stone?

By  

American Journal of Nephrology, Vol. 42, Iss. 6, 2015-0 ,pp. : 389-390

Karger

Access to resources Recommend Favorite

Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis

By  

Blood Purification, Vol. 44, Iss. 2, 2017-05 ,pp. : 122-128

Karger

Access to resources Recommend Favorite

Refeeding Hypophosphatemia in a Chronically Hyperphosphatemic Hemodialysis Patient

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 552-552

Karger

Access to resources Recommend Favorite

Relationship of Fibroblast Growth Factor 23 with Left Ventricle Mass Index and Coronary Calcificaton in Chronic Renal Disease

By  

Kidney and Blood Pressure Research, Vol. 36, Iss. 1, 2012-08 ,pp. : 55-64

Karger

Access to resources Recommend Favorite